Literature DB >> 21747263

Use of negative pressure wound therapy with silver base dressing for necrotizing fasciitis.

Saman Mohammadi Pour1.   

Abstract

BACKGROUND: Necrotizing fasciitis is a life-threatening infection requiring urgent surgical and medical therapy. Hemodynamic stabilization and antimicrobial therapy precede aggressive surgical excision of necrotic tissue, which should be performed as soon as possible. The rapidly spreading infection and aggressive surgical intervention create challenges for wound management. Multiple dressings are available to address the various challenges associated with management of these wounds; this article discusses negative pressure therapy and antimicrobial dressings in the management of Fournier's gangrene, a form of necrotizing fasciitis that involves tissue of the genital or perianal areas. CASE
PRESENTATION: This article reviews the case of a 56-year-old man with fever, tachycardia, and perianal pain associated with necrotizing fasciitis. Extensive surgical debridement was done on the day of admission. After several irrigations, the wound was dressed by negative pressure wound therapy with a silver dressing that minimized hospital stay and enabled early reconstruction.
CONCLUSION: We found that negative pressure wound therapy with a silver-based dressing promoted wound healing and provided a solid matrix for surgical reconstruction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21747263     DOI: 10.1097/WON.0b013e31821e43f1

Source DB:  PubMed          Journal:  J Wound Ostomy Continence Nurs        ISSN: 1071-5754            Impact factor:   1.741


  2 in total

1.  Fournier's gangrene current approaches.

Authors:  Omer F Ozkan; Neset Koksal; Ediz Altinli; Atilla Celik; Mehmet A Uzun; Oztekin Cıkman; Alpaslan Akbas; Ersin Ergun; Hasan A Kiraz; Muammer Karaayvaz
Journal:  Int Wound J       Date:  2014-08-22       Impact factor: 3.315

2.  Unusual foreign body in the sigmoid colon, chronic alcohol abuse, and Fournier gangrene: a case report.

Authors:  Dietmar Schulz; Georgiana Simona Mohor; Caius Solovan
Journal:  Clin Interv Aging       Date:  2015-03-31       Impact factor: 4.458

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.